Results 201 to 210 of about 18,058,309 (312)

WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling

open access: yesAdvanced Science, EarlyView.
Upregulated WDR76 recruits USP14 to stabilize CBX5, promoting nuclear liquid‐liquid phase separation and DNA co‐condensation. This drives heterochromatin‐associated chromatin remodeling and stemness‐related transcriptional programs, thereby enhancing HCC stemness, tumor progression, and reduced lenvatinib sensitivity.
Jingduo Deng   +21 more
wiley   +1 more source

Ligand‐Ratio–Tuned DNA Nanocarriers Overcome Bladder Barriers for Ultralow‐Dose Intravesical Therapy

open access: yesAdvanced Science, EarlyView.
A programmable DNA framework drug carrier coordinates barrier transport, tumor targeting, and drug delivery through ligand‐ratio engineering. Systematic exploration of the Sgc8/fluorocarbon design space reveals a nonlinear optimal balance between penetration and cellular engagement, translating multifunctional integration into durable bladder tumor ...
Dunfang Liu   +5 more
wiley   +1 more source

Spray‐Dried mRNA‐LNP Powder Enabling Multi‐Route Delivery With 3‐Year Refrigerated Stability

open access: yesAdvanced Science, EarlyView.
Spray‐dried mRNA‐LNP powder with trehalose matrix enables reconstitution for parenteral delivery or direct administration via pulmonary and sublingual routes, maintaining protein expression comparable to liquid controls. The thermostable powder preserves colloidal stability, mRNA integrity, and biological activity for over 3 years at 2°C–8°C, while ...
Ashish Sarode   +4 more
wiley   +1 more source

Tolerogenic Immunotherapy for Type 1 Diabetes Through Sustained Autoantigen Delivery in a Transient Inflammatory Niche

open access: yesAdvanced Science, EarlyView.
Sustained co‐delivery of insulin autoantigen and low‐dose interleukin‐2 from an injectable hydrogel depot established a transient tolerogenic niche that expanded regulatory T cells and delayed median diabetes onset from 20 to >40 weeks in non‐obese diabetic mice.
Leslee T. Nguyen   +16 more
wiley   +1 more source

Artificial intelligence in vaccine development: applications, implementation, and future directions. [PDF]

open access: yesFront Cell Infect Microbiol
Kumar SN   +10 more
europepmc   +1 more source

Autonomous AI‐Driven Design for Skin Product Formulations

open access: yesAdvanced Intelligent Discovery, EarlyView.
This review presents a comprehensive closed‐loop framework for autonomous skin product formulation design. By integrating artificial intelligence‐driven experiment selection with automated multi‐tiered assays, the approach shifts development from trial‐and‐error to intelligent optimisation.
Yu Zhang   +5 more
wiley   +1 more source

Searching for immune correlates in Lassa vaccine development - workshop report. [PDF]

open access: yesNPJ Vaccines
Brasel T   +44 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy